ACRO BIOMEDICAL CO., LTD. Stock-Based Compensation
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Stock-Based Compensation of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-07-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-07-24
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $1.01M, a 74.30% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $3.12M, a 20.48% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $3.93M, a 0.00% change year-over-year.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for fiscal 2023 was $8.06M, a 48.70% decline from fiscal 2022.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for fiscal 2022 was $15.71M, a 105.35% increase from fiscal 2021.
- ACRO BIOMEDICAL CO., LTD. share-based payment arrangement, noncash expense for fiscal 2021 was $7.65M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-07-24 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $1.01M derived: sum of 2 quarters · filed 2025-07-24 | $4.13M derived: sum of 3 quarters · filed 2025-07-24 | $8.06M 10-K · filed 2025-07-24 |
| 2023-09-30 | $1.01M 10-Q · filed 2025-07-11 | $4.13M derived: sum of 2 quarters · filed 2025-07-11 | $8.06M 10-Q · filed 2025-07-11 | $11.99M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-06-30 | $3.12M 10-Q · filed 2023-08-14 | $7.05M 10-Q · filed 2023-08-14 | $10.98M derived: sum of 3 quarters · filed 2025-07-18 | $14.91M derived: sum of 4 quarters · filed 2025-07-18 |
| 2023-03-31 | $3.93M 10-Q · filed 2023-08-02 | $7.86M derived: sum of 2 quarters · filed 2025-07-18 | $11.78M derived: sum of 3 quarters · filed 2025-07-18 | $15.71M derived: sum of 4 quarters · filed 2025-07-18 |
| 2022-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $7.86M derived: sum of 2 quarters · filed 2025-07-18 | $11.78M derived: sum of 3 quarters · filed 2025-07-18 | $15.71M 10-K · filed 2025-07-18 |
| 2022-09-30 | $3.93M 10-Q · filed 2025-07-11 | $7.86M derived: sum of 2 quarters · filed 2025-07-11 | $11.78M 10-Q · filed 2025-07-11 | $15.71M derived: sum of 4 quarters · filed 2025-07-11 |
| 2022-06-30 | $3.93M 10-Q · filed 2023-08-14 | $7.86M 10-Q · filed 2023-08-14 | $11.78M derived: sum of 3 quarters · filed 2023-08-14 | $14.70M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $3.93M 10-Q · filed 2023-08-02 | $7.86M derived: sum of 2 quarters · filed 2023-08-02 | $10.77M derived: sum of 3 quarters · filed 2023-08-02 | |
| 2021-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-21 | $6.85M derived: sum of 2 quarters · filed 2023-07-21 | $7.65M 10-K · filed 2023-07-21 | |
| 2021-09-30 | $2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $3.72M 10-Q · filed 2022-11-21 | ||
| 2021-06-30 | $804.65K 10-Q · filed 2022-08-12 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $0.00 derived: sum of 2 quarters · filed 2022-04-15 | $0.00 10-K · filed 2022-04-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $0.00 10-Q · filed 2021-11-22 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-23 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-02 | $0.00 derived: sum of 2 quarters · filed 2021-04-02 | $0.00 derived: sum of 3 quarters · filed 2021-04-02 | $148.40K 10-K · filed 2021-04-02 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $0.00 derived: sum of 2 quarters · filed 2020-11-17 | $148.40K 10-Q · filed 2020-11-17 | $300.09K 10-KT · filed 2020-03-27 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | $148.40K 10-Q · filed 2020-08-19 | $300.09K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $148.40K 10-Q · filed 2020-05-19 | $300.09K 10-Q · filed 2019-05-15 | ||
| 2018-12-31 | $151.69K 10-K · filed 2021-04-02 | |||
| 2018-09-30 | $7.41K 10-KT · filed 2020-03-27 |